2024 Here we go again., page-667

Reckon announcement tonight.

Buyers sharply up, with more buyers than sellers - first time this week, and I've been looking closely.

Tonight is the night.

SP Predictions (not that anyone cares!):

Submission confirmation: $1.35

FDA application acceptance with type 2 review (6 months): $1.95

FDA application acceptance with type 1 review (2 months): $3.50

Approval for kids only: ($500,000 x 300 patients = $1.5 billion revenue): $5.00

The market then factors in adults ($500,000 x 3000 patients = $15 billion): $9.00

Fast-track Revascor and priced in ($500,000 x 100,000 patents = $500 billion+): $50 - $100

FDA Rejection: 15c

Saving lives, making money, it all starts with Ryoncil - just does the heavy lifting for all other FDA applications as the manufacturing and safety is identical.

Good luck to all holders - short and long term!